Vapotherm's HVT 2.0 System Overcomes Regulatory Hurdles for Entry into South America's Largest Health Care Market
- None.
- None.
The therapeutic respiratory devices market in
Joe Army, Vapotherm's President and Chief Executive Officer expressed his optimism, stating, "I'm excited about emerging market growth for Vapotherm. In the third quarter of 2023, we posted
The mobility of the HVT 2.0 platform, ease of use, multi-functionality, and the upgraded design which freed the device from requiring an external source of compressed air makes HVT 2.0 an ideal respiratory support device for care of patients ranging from pediatric to the elderly. These features facilitate optimal patient care in the most advanced hospitals as well as resource constrained environments.
With the approval of the new system in
About Vapotherm
Vapotherm, Inc. (OTCQX: VAPO) is a publicly traded developer and manufacturer of advanced respiratory technology based in
Vapotherm high velocity therapy is mask-free non-invasive respiratory support and is a front-line tool for relieving respiratory distress—including hypercapnia, hypoxemia, and dyspnea. It allows for the fast, safe treatment of undifferentiated respiratory distress with one tool. The HVT 2.0 and Precision Flow systems' mask-free interface delivers optimally conditioned breathing gases, making it comfortable for patients and reducing the risks and care complexities associated with mask therapies. While being treated, patients can talk, eat, drink and take oral medication.
Legal Notice Regarding Forward-Looking Statements
This press release contains forward-looking statements under the Private Securities Litigation Reform Act of 1995, including statements about the Company's business and growth prospects in
Investor Relations Contacts:
John Landry, SVP & CFO, ir@vtherm.com, +1 (603) 658-0011
http://investors.vapotherm.com/
1 https://www.grandviewresearch.com/industry-analysis/brazil-therapeutic-respiratory-devices-market-report
2 https://pubmed.ncbi.nlm.nih.gov/17416152/
View original content to download multimedia:https://www.prnewswire.com/news-releases/vapotherms-hvt-2-0-system-overcomes-regulatory-hurdles-for-entry-into-south-americas-largest-health-care-market-302074566.html
SOURCE Vapotherm, Inc.
FAQ
What is the recent regulatory approval announced by Vapotherm, Inc. in Brazil?
What is the market value of therapeutic respiratory devices in Brazil in 2022?
What is the expected growth rate of the therapeutic respiratory devices market in Brazil from 2023 to 2030?
What is the significance of COPD in Brazil?